Recombinant multi-species STAR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAR protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene plays a key role in the acute regulation of steroid hormone synthesis by enhancing the conversion of cholesterol into pregnenolone. This protein permits the cleavage of cholesterol into pregnenolone by mediating the transport of cholesterol from the outer mitochondrial membrane to the inner mitochondrial membrane. Mutations in this gene are a cause of congenital lipoid adrenal hyperplasia (CLAH), also called lipoid CAH. A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jul 2008]
The Alternative Names of target: D8Ertd419e,STAR,STARD1,START domain-containing protein 1 (StARD1),StAR,Star,Steroidogenic acute regulatory protein,mitochondrial,stARD1
Go
to STAR products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T33063-Ag-1/ GM-Tg-hg-T33063-Ag-2 | Human STAR protein | Human |
| GM-Tg-rg-T33063-Ag-1/ GM-Tg-rg-T33063-Ag-2 | Rat STAR protein | Rat |
| GM-Tg-mg-T33063-Ag-1/ GM-Tg-mg-T33063-Ag-2 | Mouse STAR protein | Mouse |
| GM-Tg-cynog-T33063-Ag-1/ GM-Tg-cynog-T33063-Ag-2 | Cynomolgus/Rhesus macaque STAR protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T33063-Ag-1/ GM-Tg-felg-T33063-Ag-2 | Feline STAR protein | Feline |
| GM-Tg-cang-T33063-Ag-1/ GM-Tg-cang-T33063-Ag-2 | Canine STAR protein | Canine |
| GM-Tg-bovg-T33063-Ag-1/ GM-Tg-bovg-T33063-Ag-2 | Bovine STAR protein | Bovine |
| GM-Tg-equg-T33063-Ag-1/ GM-Tg-equg-T33063-Ag-2 | Equine STAR protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T33063-Ag-1/ GM-Tg-hg-T33063-Ag-2;
GM-Tg-rg-T33063-Ag-1/ GM-Tg-rg-T33063-Ag-2;
GM-Tg-mg-T33063-Ag-1/ GM-Tg-mg-T33063-Ag-2; GM-Tg-cynog-T33063-Ag-1/ GM-Tg-cynog-T33063-Ag-2; GM-Tg-felg-T33063-Ag-1/ GM-Tg-felg-T33063-Ag-2; GM-Tg-cang-T33063-Ag-1/ GM-Tg-cang-T33063-Ag-2; GM-Tg-bovg-T33063-Ag-1/ GM-Tg-bovg-T33063-Ag-2; GM-Tg-equg-T33063-Ag-1/ GM-Tg-equg-T33063-Ag-2 |
| Products Name | STAR protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | STAR |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine STAR protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.